Anti-PD-1 alone

BIOLOGICAL2 trials

Sponsors

Capital Medical University

Conditions

Lung CancerNeoplasms

Phase 1

Anti-PD-1 Alone or Combined With Autologous DC-CIK Cell Therapy in Advanced Solid Tumors

CompletedNCT03190811

Capital Medical UniversityNeoplasms

Start: 2016-09-30End: 2023-06-30Updated: 2024-02-07

Anti-PD-1 Alone or Combined With Autologous Cell Therapy in Advanced NSCLC

CompletedNCT03360630

Capital Medical UniversityLung Cancer, Neoplasms

Start: 2016-11-01End: 2023-06-01Updated: 2024-02-07